We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-6.1%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$13.5M
AUM Growth
-$1.55M
Cap. Flow
+$17.1M
Cap. Flow %
126.71%
Top 10 Hldgs %
54.64%
Holding
84
New
22
Increased
18
Reduced
8
Closed
28

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$801K
2
WEAV icon
Weave Communications
WEAV
+$715K
3
VKTX icon
Viking Therapeutics
VKTX
+$662K
4
SRG
Seritage Growth Properties
SRG
+$385K
5
ML
MoneyLion Inc.
ML
+$305K

Top Sells

Rank Stock Value
1
AIP icon
Arteris
AIP
+$1.01M
2
IHI icon
iShares US Medical Devices ETF
IHI
+$908K
3
INSM icon
Insmed
INSM
+$597K
4
APLS
Apellis Pharmaceuticals
APLS
+$453K
5
NVO
Novo Nordisk
NVO
+$385K

Sector Composition

Rank Sector Weight
1 Healthcare 30.58%
2 Real Estate 24.99%
3 Technology 20.99%
4 Communication Services 7.7%
5 Financials 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGY icon
26
Pagaya Technologies
PGY
$1.35B
$172K 1.28%
13,478
+1,625
+14% +$18.2K
OPRA
27
Opera Ltd
OPRA
$1.68B
$159K 1.18%
11,300
+950
+9% +$13.5K
MGNI icon
28
Magnite
MGNI
$2.83B
$158K 1.17%
+11,890
New +$130K
YMM icon
29
Full Truck Alliance
YMM
$10B
$138K 1.03%
+17,212
New +$146K
WULF icon
30
TeraWulf
WULF
$7.48B
$130K 0.96%
29,156
+5,031
+21% +$13.6K
MAMA icon
31
Mama's Creations
MAMA
$846M
$123K 0.91%
18,256
+2,500
+16% +$15.2K
RBBN icon
32
Ribbon Communications
RBBN
$386M
$123K 0.91%
37,338
+7,600
+26% +$23.1K
SAGE
33
CALL
DELISTED
Sage Therapeutics
SAGE
$122K 0.9%
+214,900
New +$2.75M
TERN
34
DELISTED
Terns Pharmaceuticals
TERN
$119K 0.88%
+17,470
New +$106K
QURE icon
35
CALL
uniQure
QURE
$2.78B
$100K 0.74%
202,000
+170,700
+545% +$831K
BTBT icon
36
Bit Digital
BTBT
$428M
$93.1K 0.69%
29,279
+9,805
+50% +$24K
MQ icon
37
Marqeta
MQ
$1.93B
$80.7K 0.6%
3,684
-160
-4% -$3.52K
CRNT icon
38
Ceragon Networks
CRNT
$188M
$69.9K 0.52%
27,957
-18,639
-40% -$51K
BLZE icon
39
Backblaze
BLZE
$683M
$67K 0.5%
+10,871
New +$84.8K
ADTN icon
40
Adtran
ADTN
$675M
$65.1K 0.48%
+12,375
New +$63.1K
VKTX icon
41
CALL
Viking Therapeutics
VKTX
$3.88B
$64.5K 0.48%
+95,400
New +$6.25M
DNN icon
42
Denison Mines
DNN
$2.43B
$64.4K 0.48%
32,375
+7,375
+30% +$15.7K
NOK icon
43
Nokia
NOK
$46.9B
$63.3K 0.47%
+16,750
New +$61.9K
NVTS icon
44
Navitas Semiconductor
NVTS
$2.54B
$49.1K 0.36%
+12,500
New +$52.6K
XNTK icon
45
PUT
State Street SPDR NYSE Technology ETF
XNTK
$1.94B
$40.5K 0.3%
21,500
+6,100
+40% +$1.12M
AXTI icon
46
AXT Inc
AXTI
$2.42B
$40.1K 0.3%
+11,875
New +$41.5K
LTRX icon
47
Lantronix
LTRX
$223M
$36.2K 0.27%
10,207
-10,207
-50% -$36.6K
ALEC icon
48
CALL
Alector
ALEC
$169M
$36.1K 0.27%
+23,300
New +$120K
VKTX icon
49
PUT
Viking Therapeutics
VKTX
$3.88B
$33.8K 0.25%
+11,600
New +$760K
STIM icon
50
Neuronetics
STIM
$127M
$28.5K 0.21%
15,823
-1,055
-6% -$3.04K
1
2
3 4

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Worth Venture Partners held 84 positions worth $13.5M, down 10% from $15M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Worth Venture Partners deployed $17.1M of net new capital in Q2 2024, opening 22 new positions and adding to 18 existing holdings. Its largest new stake was Pfizer: 29,100 shares worth $814K.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was Innovid Corp., an estimated $64.2K trimmed.

  • Worth Venture Partners's largest Q2 2024 buy was Pfizer: 29,100 shares worth $814K.
  • Worth Venture Partners added most to Weave Communications in Q2 2024, an estimated $715K increase.
  • Worth Venture Partners's biggest Q2 2024 reduction was Innovid Corp., cutting an estimated $64.2K.
  • Worth Venture Partners fully exited Arteris in Q2 2024, selling an estimated $1.01M.
  • Worth Venture Partners's ten largest holdings make up 55% of its $13.5M portfolio in Q2 2024.
  • Worth Venture Partners opened 22 new positions and closed 28 in Q2 2024.
  • Worth Venture Partners's portfolio value fell 10% quarter-over-quarter to $13.5M.

Based on Worth Venture Partners's 13F filing for Q2 2024, filed 14 Aug 2024.